Kenvue Inc stock is traded at $19.31, with a volume of 66,596,317. It is down -1.28% in the last 24 hours and up +12.27% over the past month. Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold, and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced in November 2025 that it signed a deal to be fully acquired by Kimberly-Clark, with the deal expected to close during the second half of 2026.
Previous Close:
$19.56
Open:
$19.99
24h Volume:
66,596,317
Relative Volume:
3.31
Market Cap:
$37.11B
Revenue:
$15.29B
Net Income/Loss:
$1.62B
P/E Ratio:
22.90
EPS:
$0.8433
Net Cash Flow:
$1.82B
1W Performance:
-0.10%
1M Performance:
+12.27%
6M Performance:
+12.59%
1Y Performance:
+20.91%
1-Day Range:
$0.00$0.00
1-Week Range:
$0.00$0.00
52-Week Range:
$14.02$20.13
Kenvue Inc Stock (KVUE) Company Profile
Name
Kenvue IncSector
Consumer DefensiveIndustry
Household & Personal ProductsPhone
908-874-1200Address
1 KENVUE WAY, SUMMIT, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS